Pilot Study to Evaluate the Impact of Denosumab on Disseminated Tumor Cells (DTC) in Patients With Early Stage Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Early Stage Breast Cancer
Interventions: DRUG: Denosumab
Sponsor: Hope Rugo, MD
Collaborators: University of California, San Francisco|Amgen